What is CHD Bioscience?
Headquartered in Fort Collins, Colorado, CHD Bioscience operates at the intersection of clinical hygiene and pharmaceutical innovation. The company specializes in the development of proprietary disinfectant agents engineered to eradicate high-risk pathogens that contribute to the escalating crisis of healthcare-associated infections. By focusing on both human and veterinary applications, CHD Bioscience addresses a critical market gap in global health security, aiming to standardize infection prevention protocols across diverse clinical environments. Their strategic focus remains on the discovery and commercialization of high-efficacy antimicrobial solutions that serve both industrialized and emerging economies.
How much funding has CHD Bioscience raised?
CHD Bioscience has raised a total of $10.9M across 4 funding rounds:
Private Equity
$3.2M
Private Equity
$1.7M
Private Equity
$3.3M
Private Equity
$2.7M
Private Equity (2014): $3.2M, investors not publicly disclosed
Private Equity (2015): $1.7M, investors not publicly disclosed
Private Equity (2016): $3.3M, investors not publicly disclosed
Private Equity (2017): $2.7M, investors not publicly disclosed
Key Investors in CHD Bioscience
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for CHD Bioscience?
With this major enterprise-level funding, CHD Bioscience is poised to transition from its current development phase into a broader commercial scaling strategy. The capital will likely be deployed to bolster clinical trial pipelines, expand manufacturing capabilities, and navigate the complex regulatory frameworks required for international market entry. As the global demand for robust infection control measures continues to rise, the company's ability to scale its proprietary technology will be a key indicator of its long-term market dominance. Future growth will likely center on strategic partnerships with healthcare systems and veterinary networks to integrate their disinfectant solutions into standard operating procedures, thereby solidifying their position as a leader in the biosecurity sector.
See full CHD Bioscience company page
